Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Two reasons why Novavax stock is down over 20% today

Published 15-12-2022, 08:20 pm
© Reuters
NVAX
-

By Senad Karaahmetovic

Shares of Novavax (NASDAQ:NVAX) are trading about 20% lower Thursday, further highlighting the catastrophic year for the stock, which is down 88% year-to-date (YTD) based on yesterday’s close.

Novavax stock was hit yesterday after-hours after the company said it offered $125 million of shares and $125M of convertible bonds. For Bloomberg Intelligence analysts, the dual offering doesn’t “inspire confidence in Covid-19 vaccine profitability.”

They also said that they won’t be surprised if Novavax was forced to raise more funds in the future, which would hurt the NVAX stock again.

Moreover, the biotech firm said its deal to supply Covid-19 vaccines to the U.K. was slashed to 7.5M conditional doses from the previous 15M doses after it failed to secure a supportive recommendation from the U.K. Joint Committee on Vaccination and Immunisation by November 30.

As a result, Novavax is forced to repay $112.5M pertaining to the upfront payment previously received from the U.K.

Despite this development, Novavax reiterated its full-year forecast for revenue of $2 billion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.